CJC-1295 is built in a lab from protein parts; scientists call this kind of chain a peptide.

What happens after a CJC-1295 shot?

CJC-1295 goes to work at the growth gland. It copies the brain's normal request for growth hormone, the gland answers, and the hormone goes into the blood in bursts ^[4]. In 1989, Bilezikjian and Vale showed how that works using rat gland cells in a dish. The stronger the request, the more growth hormone the cells let out ^[4]. They also measured how weak the request could be and still work well. That answer, written in lab shorthand as 10 to the minus 8, is a dish measurement; you can't compare it with a shot in a person.

What CJC-1295 mainly changes is how long the request lasts. Blocks 2, 8, 15, and 27 were swapped so it wears out more slowly in the body ^[6]. The long-lasting CJC-1295 form also carries a small hook. Within minutes of a shot, the hook grabs albumin, among the commonest proteins in blood, which itself stays around about 19 days. Riding along with it, half the peptide was gone after 5.8-8.1 days; each dose group had its own average, all inside that span ^[1]. The shorter CJC-1295 form has the same swaps but no hook. Half of it was gone in about 30 minutes ^[6].

Once growth hormone rises, the liver makes IGF-1, a second hormone, in reply ^[1][11]. Studies used IGF-1 as their blood-test yardstick. Teichman's 2006 study found one point worth keeping: even the long-lasting form let growth hormone come out in bursts. It didn't flatten the body's natural rise and fall into one steady flow ^[1].

What is the strongest CJC-1295 finding?

The strongest finding is Teichman's 2006 study in healthy adults aged 21-61. Each got one long-lasting CJC-1295 shot just under the skin. Doses were 30, 60, 125, and 250 micrograms, matched to each person's weight in kilograms. Those are tiny amounts, since a gram holds a million micrograms. On average, growth hormone went 2- to 10-fold above normal, two to ten times, and stayed there six days or longer. IGF-1, the liver's answering hormone, rose 1.5- to 3-fold and stayed up nine to eleven days ^[1]. With repeat shots, IGF-1 sat higher than where it began for up to 28 days, over 28- and 49-day stretches ^[1]. The authors called the lower two amounts fairly well tolerated ^[1]. That's a thin phrase, and it tells you nothing about years of use.

Now the caveats. Alba's team tested CJC-1295 in mice in 2006. These mice were born without a gene they need to grow normally. Daily shots began at one week old, and their size caught up to normal within five weeks. Shots at 48-hour or 72-hour gaps did less. The gland cells had geared up to make more growth hormone ^[3].

A 2009 paper found many blood proteins shifted after adults got a shot ^[5]. The shifts matched higher IGF-1 and proved nothing about health. In 2017, Sigalos found IGF-1 higher in men also taking testosterone and other growth-hormone drugs ^[11]. Neither paper shows CJC-1295 helped anyone feel better or get more done.

What is the short-lasting form of CJC-1295?

The short-lasting form has no hook for the blood protein. It still has the four swapped building blocks, numbers 2, 8, 15, and 27. Those swaps slow breakdown, but without the hook it can't ride along with albumin ^[6]. Coy's 1994 work found that swapping block 2 alone made the request last longer in men ^[6]. Sermorelin, the unchanged copy, loses half from the blood in 11-12 minutes ^[7]. The short form lasts about 30 minutes ^[6].

You may see this short form under a long lab name. Whatever the label says, it's the same peptide without the hook. In 2010, Henninge's team found CJC-1295 in an unlabeled drug seized by Norwegian customs ^[8]. Their test could tell it was CJC-1295 but not which form. Newer drug tests can now separate the two forms ^[12][14].

Has CJC-1295 with ipamorelin helped people?

Ipamorelin is another peptide. It asks the growth gland for growth hormone in a different way than CJC-1295 does, and either request can raise growth hormone in the blood. In 1998, Raun's team found that ipamorelin lifted growth hormone and left two stress hormones about level. That held even at doses far bigger than the smallest amount that lifted growth hormone. So researchers had a reason to try pairing it with CJC-1295. Whether the pair helps anyone is still unproved ^[2].

What clinics report about CJC-1295 and ipamorelin comes from their patients' accounts, not a controlled trial. No Phase 3 study, the large late-stage kind, has tested the pair. In 2017, Sigalos found IGF-1, a hormone the liver makes, higher in men given several drugs plus testosterone. There was no placebo group, meaning no group got a dummy shot with no drug in it ^[11]. So you can't tell which drug caused the rise.

CJC-1295 vs ipamorelin: do they send the same message?

CJC-1295 vs ipamorelin isn't a contest between two copies of one drug. CJC-1295 copies the brain's usual request to the growth gland ^[1]. Ipamorelin copies a different body message, one tied to hunger ^[2]. Both can end with growth hormone released. In 1998, ipamorelin didn't clearly raise cortisol or prolactin, two hormones that climb with stress, the way older drugs did ^[2]. A cleaner lab result isn't proof you'd be healthier.

Why does CJC-1295 last longer than sermorelin?

Sermorelin is a drug that copies the body's own short growth request. It has none of CJC-1295's four swaps. Half of sermorelin leaves the blood in about 11-12 minutes, whether it goes into a vein or under the skin. After a shot just under the skin, only about 6% of the sermorelin dose gets into the blood ^[7]. That low share tells you how little gets through, not that anything is harmful. Even so, the growth-hormone burst it sets off lasts 2-4 hours and peaks 30-60 minutes after the shot ^[7]. FDA approved sermorelin, sold as Geref, in 1997 for children short of growth hormone. The company later pulled it from US sale for business reasons, not safety ones.

This peptide was built to last longer. The hookless form lasts about 30 minutes. The form with the hook lasts about 8 days ^[1][6]. Both work through the same gland. The gap between them is time, not method.

CJC-1295 or a growth-hormone shot: which skips the gland?

A growth-hormone shot puts lab-made human growth hormone straight into you. CJC-1295 asks your own gland to let out its hormone in bursts ^[1]. Either one can raise IGF-1, the liver's answering hormone. Teichman's 2006 study found the long-lasting CJC-1295 form didn't smooth those bursts away; they still came and went on their own rhythm ^[1]. A growth-hormone shot goes around the gland's own controls.

CJC-1295 sends a request to the gland; deciding whether someone needs hormone treatment takes a separate medical assessment, and peptide care through Promise Peptides (mypromise.com) requires a licensed clinician's prescription.

Tesamorelin is a separate drug from the same broad family. FDA approved it in 2010 for people with HIV-associated fat build-up deep in the belly. In trials, that fat fell 15-18% on average against a placebo, a dummy treatment ^[9]. That's tesamorelin's result, and it doesn't carry over.

What does the short-form name tell you?

Some papers call hookless CJC-1295 by a long lab name. All that name records is the four swapped blocks, 2, 8, 15, and 27, which slow its breakdown ^[6]. Half of this form is gone in about 30 minutes. The hooked form has an 8-day span, and the body's own unchanged request lasts about 10 minutes ^[6][7]. So the lab name marks the form, and the form decides how long it stays with you.

How does the long-lasting CJC-1295 form stay in blood?

The peptide copies a request the growth gland already knows ^[4]. A small hook latches onto albumin, a main protein in blood, and researchers found the joined peptide still there days later ^[1]. Without the hook, half is gone in about 30 minutes, a shorter burst nearer the body's own timing ^[6]. That hook alters how long the request lasts, not what it asks.

Why do clinics pair CJC-1295 and ipamorelin?

The two peptides ask the growth gland for the same hormone in different ways. CJC-1295 copies the brain's usual request; ipamorelin copies a body message linked to hunger ^[2]. Either can put more growth hormone in the blood. That's the reasoning clinics will give you. Nobody has solid proof the pair helps ^[11].

What proof exists for the paired CJC-1295 shots?

Ipamorelin and CJC-1295 send two different requests that can each release growth hormone ^[1][2]. Clinic pages make the pairing sound settled. It isn't. What's said about the pair comes mostly from clinics, not fair trials comparing groups. In 2017, Sigalos found a growth-linked blood test higher in men taking several drugs at once ^[11]. That can't show what this pair did alone.

How much longer does CJC-1295 last than sermorelin?

Both copy the brain's request for growth hormone. Sermorelin has no swaps and lasts 11-12 minutes in the blood ^[7]. CJC-1295's four swaps make it tougher. Its short form lasts about 30 minutes. Its long form holds onto albumin, the most plentiful protein in blood, and half of it lasted 5.8-8.1 days, the average shifting a little from one dose to the next ^[1][6]. So you're weighing minutes against days.

Is CJC-1295 the same thing as growth hormone?

No. A growth-hormone shot is the hormone itself, made in a lab. CJC-1295 isn't. It calls on your growth gland, which lets out its own hormone in bursts and can lift IGF-1, the liver's answering hormone ^[1]. One brings growth hormone in from outside. The other asks your body to make it. Neither difference proves one works better.